Your Category: ERDERA

ERDERA Ethics & Regulatory webinar series: The Role of Ethics in ATMP Research and Development

The Role of Ethics in ATMP Research and Development

November 2 @ 1:00 pm - 2:00 pm
ERDERA Ethics & Regulatory Webinar Series
ERDERA Knowledge Exchange Meeting

ERDERA Knowledge Exchange Meeting on Drug Repurposing for Rare Diseases

November 25 - November 26
Discover practical pathways to repurpose medicines for rare diseases, exchange experiences and best practices between underrepresented and high-performing countries, and build new partnerships at the ERDERA Knowledge Exchange Meeting in Riga on 25-26 November.
Journée nationale FrBioNet

ERDERA connects rare disease research and biobanking at FrBioNet’s first national event

ERDERA contributed to the first Journée nationale FrBioNet, bringing a European rare disease perspective to discussions with the French biobanking community.
ERDERA - World Orphan Drug Congress - JVDPhotography-40

Can AI deliver for rare diseases? ERDERA brings the debate to WODC Europe

ERDERA will return to the World Orphan Drug Congress Europe with a booth and an interactive pre-conference workshop examining where artificial intelligence can support rare disease research and therapeutic development, and where human expertise remains essential.
Re(ACT) 2027+ (Courier) icones_page-0001

RE(ACT) Congress 2027

March 10 - March 12
Building on the legacy of the RE(ACT) Congress series (now reaching its ninth edition), RE(ACT) continues to serve as a meeting point for scientific innovation and real-world impact.
ERDERA - GAM day 2 - JVDPhotography-65

ERDERA announces its 2026 Open Session

This free online session will highlight patient and research perspectives, innovative clinical study methods, and emerging regulatory approaches
ERDERA trainings template (7)

Regulatory Insights of Advanced Therapies Research & Development

September 30 @ 1:00 pm - 2:00 pm
This ERDERA webinar will provide an overview of the regulatory and ethical requirements for advanced therapy medicinal product (ATMP) research, with a particular focus on genome editing and paediatric studies in rare diseases.
ERDERA clinical trial call

ERDERA Clinical Trial Call – Model Award Agreement

Model award agreement document setting out the structure, articles and contractual provisions applicable to funded activities.
ERDERA clinical trial call

ERDERA Clinical Trial Call – Annex IV. Guidelines for Canadian Applicants

This annex explains the specific eligibility, sponsorship, funding and application requirements for Canadian applicants in the ERDERA Clinical Trial Call.
October 2026 (5)

ERDERA’s Open Session – 3rd General Assembly Meeting

October 21 @ 2:30 pm - 5:30 pm
A special anniversary event showcasing how innovation, collaboration and novel trial methodologies are advancing rare disease research.
VIEW MORE

ERDERA Search